Logo

GenoSense Licenses Genetic Technologies' DNA Patents; Firms Hint at Other Deals

Dec 21, 2006
NEW YORK (GenomeWeb News) — Genetic Technologies today said it has licensed its non-coding DNA patents to Viennese diagnostics company GenoSense.
 
Under the nine-year deal, GenoSense bought worldwide licensing rights to use Genetic Technologies’ technology in its anti-aging diagnostics and preventive testing services.
 
In a statement, the companies also said the “have identified a number of mutually beneficial global business opportunities that will be explored over the coming months.” The statement didn’t elaborate.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.